These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. Ni X; Zhang C; Talpur R; Duvic M J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832 [TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma. Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649 [TBL] [Abstract][Full Text] [Related]
8. EPHA4 is overexpressed but not functionally active in Sézary syndrome. Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients. Kohnken R; Kodigepalli KM; Mishra A; Porcu P; Wu L Leuk Res; 2017 Jan; 52():58-66. PubMed ID: 27889686 [TBL] [Abstract][Full Text] [Related]
10. Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma. Butler LM; Dobrovic A; Bianco T; Cowled PA Br J Cancer; 2000 Jan; 82(1):131-5. PubMed ID: 10638979 [TBL] [Abstract][Full Text] [Related]
11. Epigenomic Analysis of Sézary Syndrome Defines Patterns of Aberrant DNA Methylation and Identifies Diagnostic Markers. van Doorn R; Slieker RC; Boonk SE; Zoutman WH; Goeman JJ; Bagot M; Michel L; Tensen CP; Willemze R; Heijmans BT; Vermeer MH J Invest Dermatol; 2016 Sep; 136(9):1876-1884. PubMed ID: 27113428 [TBL] [Abstract][Full Text] [Related]
12. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes. Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription. Wang Y; Su M; Zhou LL; Tu P; Zhang X; Jiang X; Zhou Y Blood; 2011 Apr; 117(14):3826-35. PubMed ID: 21270445 [TBL] [Abstract][Full Text] [Related]
14. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome. van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192 [TBL] [Abstract][Full Text] [Related]
16. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status. Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509 [TBL] [Abstract][Full Text] [Related]
17. Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma. Whittaker S J Invest Dermatol; 2016 Sep; 136(9):1753-1754. PubMed ID: 27542296 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of T-plastin in Sezary cells. Su MW; Dorocicz I; Dragowska WH; Ho V; Li G; Voss N; Gascoyne R; Zhou Y Cancer Res; 2003 Nov; 63(21):7122-7. PubMed ID: 14612505 [TBL] [Abstract][Full Text] [Related]